Pilot Study Examining the Frequency of Several Gene Polymorphisms Involved in Morphine Pharmacodynamics and Pharmacokinetics in a Morbidly Obese Population

[1]  A. Yasunaga,et al.  Association of a polymorphism of ABCB1 with obesity in Japanese individuals. , 2008, Genomics.

[2]  L. Ray,et al.  Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. , 2007, Archives of general psychiatry.

[3]  Li Jin,et al.  OPRM1 Gene Is Associated With BMI in Uyghur Population , 2009, Obesity.

[4]  A. Dahan,et al.  Polymorphism of &mgr;-Opioid Receptor Gene (OPRM1:c.118A>G) Does Not Protect Against Opioid-induced Respiratory Depression despite Reduced Analgesic Response , 2005, Anesthesiology.

[5]  P. Joyce,et al.  A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression , 2002, The Pharmacogenomics Journal.

[6]  Werner Siegmund,et al.  The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol , 2002, Clinical pharmacology and therapeutics.

[7]  M. Kasuga,et al.  MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. , 2006, Drug metabolism and pharmacokinetics.

[8]  Michel Eichelbaum,et al.  Interindividual variability of canalicular ATP‐binding‐cassette (ABC)–transporter expression in human liver , 2006, Hepatology.

[9]  E. Kharasch,et al.  Role of P‐glycoprotein in the intestinal absorption and clinical effects of morphine , 2003, Clinical pharmacology and therapeutics.

[10]  J. Long,et al.  μ opioid receptor gene variants: lack of association with alcohol dependence , 1997, Molecular Psychiatry.

[11]  Hans-Jürgen Möller,et al.  A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits , 2003, Biological Psychiatry.

[12]  E. Shimizu,et al.  Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[13]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[14]  P. Schlattmann,et al.  Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing , 2003, Biological Psychiatry.

[15]  C. Ulrich,et al.  The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. , 2004, Obesity research.

[16]  N. Bebek,et al.  Genotype and Allele Frequencies of MDR-1 C 3435 T Polymorphism in Turkish Population , 2005 .

[17]  R. Rosmond,et al.  Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. , 2008, Metabolism: clinical and experimental.

[18]  U. Brinkmann,et al.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Lötsch,et al.  Analgesic effects of morphine and morphine‐6‐glucuronide in a transcutaneous electrical pain model in healthy volunteers , 2003, Clinical pharmacology and therapeutics.

[20]  J A Tischfield,et al.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Housman,et al.  Identification of Sequence Variants and Analysis of the Role of the Catechol-O-Methyl-Transferase Gene in Schizophrenia Susceptibility , 1998, Biological Psychiatry.

[22]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Kolachana,et al.  Variation in dopamine genes influences responsivity of the human reward system , 2009, Proceedings of the National Academy of Sciences.

[24]  H. Lachman,et al.  Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophrenia , 1997, Biological Psychiatry.

[25]  R. Kim.  MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences. , 2002, Pharmacogenetics.

[26]  C. Jepson,et al.  Association of OPRM1 A118G variant with the relative reinforcing value of nicotine , 2006, Psychopharmacology.

[27]  M. Owen,et al.  No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. , 1996, The American journal of psychiatry.

[28]  N. Volkow,et al.  Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[29]  Caroline Reid,et al.  Dopamine for “Wanting” and Opioids for “Liking”: A Comparison of Obese Adults With and Without Binge Eating , 2009, Obesity.

[30]  N. Bebek,et al.  Research Article Genotype and Allele Frequencies of MDR-1 C3435T Polymorphism in Turkish Population , 2005 .

[31]  J. Ott,et al.  Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden , 2004, Molecular Psychiatry.

[32]  M. Pirmohamed,et al.  Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver. , 2005, British journal of clinical pharmacology.

[33]  D. Oslin,et al.  A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients , 2008, Psychopharmacology.

[34]  Marc Beaussier,et al.  Environmental and genetic factors associated with morphine response in the postoperative period , 2006, Clinical pharmacology and therapeutics.

[35]  J. Mallet,et al.  Linkage disequilibrium on the COMT gene in French schizophrenics and controls. , 1999, American journal of medical genetics.

[36]  P. Olszewski,et al.  Central opioids and consumption of sweet tastants: When reward outweighs homeostasis , 2007, Physiology & Behavior.

[37]  T. Lehtimäki,et al.  Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics , 2003, European Neuropsychopharmacology.

[38]  S. Joel,et al.  Clinical response to morphine in cancer patients and genetic variation in candidate genes , 2005, The Pharmacogenomics Journal.

[39]  Joshua A. Bueller,et al.  COMT val158met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor , 2003, Science.

[40]  Gérard Saillant,et al.  Postoperative Morphine Consumption in the Elderly Patient , 2003, Anesthesiology.

[41]  A. Levine,et al.  Reward systems and food intake: role of opioids , 2009, International Journal of Obesity.

[42]  H. Herken,et al.  Catechol‐O ‐methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis , 2001, Psychiatric genetics.

[43]  N. Božina,et al.  The influence of 5-HT2C and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients , 2008, Psychiatry Research.

[44]  R. Wiers,et al.  Relatively strong automatic appetitive action‐tendencies in male carriers of the OPRM1 G‐allele , 2009, Genes, brain, and behavior.

[45]  J. Lötsch,et al.  A rapid screening method for a single nucleotide polymorphism (SNP) in the human MOR gene. , 2001, British journal of clinical pharmacology.

[46]  W. Haefeli,et al.  Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine. , 2000, British journal of clinical pharmacology.

[47]  B. Wolfe,et al.  Perioperative safety in the longitudinal assessment of bariatric surgery. , 2009, The New England journal of medicine.

[48]  G. Kirov,et al.  Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. , 2002, American journal of medical genetics.

[49]  B. Meibohm,et al.  G2677T and C3435T Genotype and Haplotype Are Associated With Hepatic ABCB1 (MDR1) Expression , 2006, Journal of clinical pharmacology.

[50]  J. Lötsch,et al.  The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. , 2002, Pharmacogenetics.

[51]  Andrew A Somogyi,et al.  Pharmacogenetics of Opioids , 2007, Clinical pharmacology and therapeutics.

[52]  E. Bruera,et al.  Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene , 2007, PAIN.

[53]  Hongyu Zhao,et al.  Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European‐Americans , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[54]  J. Mortimer,et al.  A functional polymorphism within the μ-opioid receptor gene and risk for abuse of alcohol and other substances , 2002, Molecular Psychiatry.

[55]  P. Faris,et al.  Pain thresholds in obese binge-eating disorder subjects , 1995, Biological Psychiatry.

[56]  J. Lötsch,et al.  The μ-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers , 2006 .

[57]  K. Dahlen,et al.  ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individuals , 2006, Clinical pharmacology and therapeutics.

[58]  B. Jawan,et al.  Human Opioid Receptor A118G Polymorphism Affects Intravenous Patient-controlled Analgesia Morphine Consumption after Total Abdominal Hysterectomy , 2006, Anesthesiology.

[59]  R. Feinn,et al.  Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. , 2006, Drug and alcohol dependence.

[60]  D. Flum,et al.  Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. , 2005, JAMA.

[61]  E. Claus,et al.  Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. , 2008, Alcoholism, clinical and experimental research.

[62]  M. Nöthen,et al.  Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. , 2001, American journal of medical genetics.

[63]  R. Maia,et al.  ABCB1 single nucleotide polymorphisms in the Brazilian population , 2009, Molecular Biology Reports.

[64]  K. Clément,et al.  Pharmacology of Morphine in Obese Patients , 2009, Clinical pharmacokinetics.

[65]  C. Meisel,et al.  Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease , 2007, European Journal of Clinical Pharmacology.

[66]  C. Benkelfat,et al.  Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. , 2002, Archives of general psychiatry.

[67]  Andrew D. Johnson,et al.  Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G* , 2005, Journal of Biological Chemistry.

[68]  I. Sora,et al.  How individual sensitivity to opiates can be predicted by gene analyses. , 2005, Trends in pharmacological sciences.

[69]  S. Kaasa,et al.  The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease , 2004, Acta anaesthesiologica Scandinavica.

[70]  U. Hofmann,et al.  Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. , 2002, British journal of clinical pharmacology.

[71]  D. Oslin,et al.  A genetic association study of the mu opioid receptor and severe opioid dependence , 2003, Psychiatric genetics.

[72]  A. Rane,et al.  Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. , 2005, British journal of clinical pharmacology.

[73]  T. Spector,et al.  Obesity is Associated with Genetic Variants That Alter Dopamine Availability , 2006, Annals of human genetics.

[74]  A. Hariri,et al.  Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity , 2009, Molecular Psychiatry.

[75]  A. Concejero,et al.  Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. , 2006, Acta anaesthesiologica Scandinavica.

[76]  R. McCarthy,et al.  Postoperative Hypoxemia in Morbidly Obese Patients With and Without Obstructive Sleep Apnea Undergoing Laparoscopic Bariatric Surgery , 2008, Anesthesia and analgesia.

[77]  D. Campa,et al.  Association of ABCB1/MDR1 and OPRM1 Gene Polymorphisms With Morphine Pain Relief , 2008, Clinical pharmacology and therapeutics.

[78]  W. Chou,et al.  Association of μ‐opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty , 2006 .

[79]  B. Stricker,et al.  MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine , 2006, Clinical pharmacology and therapeutics.

[80]  G. Koren,et al.  Polymorphism of the MDR1/ABCB1 C3435T drug‐transporter and resistance to anticonvulsant drugs: A meta‐analysis , 2009, Epilepsia.

[81]  Lin He,et al.  Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis , 2005, Biological Psychiatry.

[82]  C. Meisel,et al.  Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects , 2001, Clinical pharmacology and therapeutics.

[83]  Bernard F Fuemmeler,et al.  Genes Implicated in Serotonergic and Dopaminergic Functioning Predict BMI Categories , 2008, Obesity.